
|Articles|June 16, 2023
Regulatory Spotlight - Compendia Updates: USP <621> and USP <1220>
Author(s)Eurofins BioPharma Product Testing
Compendia publications are periodically updated in order to align with industry trends and harmonize with global regulatory practices. Staying abreast of these changes well before they are implemented, and being ready to adapt as necessary, is in the best interest of any bio/pharmaceutical testing laboratory. Eurofins BioPharma Product Testing has proactively adjusted its procedures, collaborating with stakeholders and providing feedback to ensure smooth integration and minimal impact on existing testing methods.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Syngene Extends Major Research Collaboration with BMS
2
Sharp Expands European Injectable Packaging Capacity With €20 million Investment
3
The Shift from Containment to Protection: Packaging Trends Impacting Pharma
4
State of the Bio/Pharma Workforce: A Comparative Analysis of Employment Trends and Industry Sentiment
5